Childhood granulomatous periorificial dermatitis

Lore & Background

CGPD occurs most often in children of Afro-Caribbean descent before puberty, though reports of this disease occurring in Asian and Caucasian children have also been described. Due to the limited number of reported cases, it remains controversial whether CGPD occurs more often in African children than in children of other races. The original 1970 description by Gianotti was in five Italian children.

Reader's Guide

Diagnosis is controversial. Some dermatologists suggest ruling out infectious and allergic causes and performing a skin biopsy showing non-tuberculous granulomas with surrounding lymphocytes clustered around hair follicles, and infiltrates of epithelioid macrophages, lymphocytes, and giant cells. Others advocate for a complete history, physical exam, labs, and imaging to rule out cutaneous sarcoidosis. Treatment varies and may include observation, stopping topical corticosteroids, topical or oral antibiotics, isotretinoin, or topical calcineurin inhibitors (results mixed). Topical azelaic acid has been used successfully. Tetracycline antibiotics are not recommended for children under 8 due to tooth staining and impaired bone growth.

Did You Know?

• CGPD was first described in 1970 by Gianotti in five Italian children.
• The term 'facial Afro-Caribbean childhood eruption (FACE)' was proposed in 1990 by Williams et al. for a similar eruption in five Afro-Caribbean children.
• CGPD skin lesions rarely affect areas other than the face.
• The skin papules typically resolve after a few months to a few years, sometimes leaving small scars or depressions.

Clinical Presentation & Diagnostic Challenges

CGPD presents as a cluster of small, raised, dome-shaped papules that are flesh-colored or yellow-brown in hue. These lesions concentrate around the perioral region, the eyes, and the nose, though they can extend to the ears, eyelids, cheeks, and forehead. Notably, involvement beyond the facial region is exceedingly rare. The condition is more frequently observed in boys than in girls. Diagnosing CGPD remains a point of debate among dermatologists. One school of thought holds that excluding infectious and allergic mimics, combined with a skin biopsy showing characteristic features, is sufficient. A more cautious faction insists on a thorough history, full physical examination, laboratory work, and imaging to definitively exclude cutaneous sarcoidosis. Under the microscope, pathologists may identify non-tuberculous granulomas with lymphocytes gathered around hair follicles, along with infiltrates of epithelioid macrophages and multinucleated giant cells. The differential diagnosis is extensive, spanning perioral dermatitis, acne vulgaris, granulomatous rosacea, contact dermatitis, folliculitis, atopic dermatitis, cheilitis, medication-induced eruptions, lupus miliaris disseminatus faciei, benign cephalic histiocytosis, granulosis rubra nasi, xanthomas, zinc deficiency, glucagonoma, cutaneous sarcoidosis, and scabies.

Treatment Approaches & Their Limitations

Because CGPD is benign and self-limiting, some clinicians simply recommend watchful waiting without any intervention. When treatment is pursued, the first step often involves immediately discontinuing topical corticosteroids, which are believed to aggravate the condition. Topical antibiotics such as metronidazole and erythromycin have been applied to affected areas, while oral tetracycline-class agents—minocycline, doxycycline, and tetracycline itself—have been prescribed systemically. Trimethoprim-sulfamethoxazole is another oral option that has seen use. However, systemic antibiotics carry notable drawbacks, including nausea, vomiting, and increased photosensitivity. A critical restriction applies to tetracyclines: they are contraindicated in children younger than eight years because these drugs deposit in developing teeth, causing permanent staining, and can impair bone growth. Topical calcineurin inhibitors like tacrolimus and pimecrolimus occupy a contested space in CGPD management. Some studies report full resolution of papules with these agents, while others document only partial improvement or persistent symptoms over time. Topical azelaic acid has also been employed with reported success. The overall therapeutic picture is one of heterogeneous evidence, with no single universally endorsed protocol.

Prognosis & Long-Term Skin Outcomes

One of the most reassuring aspects of CGPD is its inherently temporary and benign trajectory. The granulomatous papules that define the condition typically fade on their own over a period ranging from a few months to several years, without requiring aggressive intervention. The underlying etiology remains unidentified, yet the disease course is consistently self-resolving. The long-term cosmetic outcome varies from child to child. In many cases, once the papules disappear, the facial skin reverts to its pre-eruption state with no visible trace of the condition. However, a subset of patients is left with subtle residual changes. These can include small atrophic depressions where collagen has been lost, tiny milia, or minute pit-like scars in the areas previously affected. Importantly, these sequelae are minor and do not represent a progressive or disfiguring process. The absence of a known cause, combined with the lack of a single definitive treatment protocol, means that management often centers on reassurance and monitoring rather than aggressive therapy, particularly given the condition's predictable resolution.

Historical Context, Nomenclature & Epidemiology

The condition now recognized as CGPD entered the medical literature in 1970 when Gianotti and colleagues published a case series describing five Italian children with a distinctive facial eruption. For two decades the entity remained relatively obscure until 1990, when Williams and co-authors reported a similar presentation in five children of Afro-Caribbean heritage and proposed the label "facial Afro-Caribbean childhood eruption," abbreviated as FACE. The term CGPD was subsequently introduced by Katz and Lesher, who argued that restricting the name to Afro-Caribbean descent was inaccurate because cases had been documented in children of other backgrounds, and they wished to sidestep confusion with the more common perioral dermatitis. Epidemiologically, CGPD is a rare disorder that predominantly affects prepubertal children of Afro-Caribbean descent, though descriptions exist in Asian and Caucasian pediatric populations as well. Because the total number of reported cases remains small, it is still debated whether the condition truly carries a higher prevalence in children of African heritage or whether reporting bias accounts for the apparent skew. Across all populations, boys are affected more often than girls. The cause of CGPD has never been identified, and it remains a benign granulomatous dermatitis of unknown origin.